Day 2 of 11 th Annual World Patient Safety, Science & Technology Summit Highlights Importance of Collaboration and Advanced Technologies
The second day of the 11th Annual World Patient Safety, Science & Technology Summit, presented by the Patient Safety Movement Foundation (PSMF) on the UC Irvine campus, underscored the theme of collaboration as essential in creating a future in which no patients are harmed by preventable medical errors and technologies continue to evolve at an accelerated pace to advance patient care.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240907191633/en/
The Global Interprofessional Patient Safety Fellowship at the 2024 PSMF Summit. From left to right: Dr. Michael A.E. Ramsay, Chief Executive Officer of PSMF; Dr. Mike Durkin, Chair of PSMF and Senior Advisor on Patient Safety Policy and Leadership, Institute of Global Health Innovation, Imperial College London; Luis Torres Torija Arguelles, MD, MBA, Ambassador of PSMF, Mexico; Natalia Camargo, RN and healthcare quality management specialist, Sao Paulo, Brazil; Afifa Munawar, BScN, MSPH, Technical Officer, Quality Patient Safety and Hospital Sector of WHO Country Office Pakistan; Angeli Merci Mejia Porto, MD, FPOGS, Obstetrician and Gynecologist at Region II Trauma and Medical Center, Philippines; Dr. Peter Lachman, Lead Faculty Quality Improvement, Royal College of Physicians of Ireland; Sanaz Massoumi, MS, PhD, Chief Operating Officer of PSMF; Joe Kiani, Founder of the Patient Safety Movement Foundation. (Photo: Business Wire)
“The future of healthcare is rapidly changing around the world,” said PSMF Founder Joe Kiani. “We need all hands on deck, including patients and their families. I hope everyone walks away from this year’s Summit with clarity on how they will contribute to reaching zero preventable medical harm. The most important lesson is that we don’t need to do it alone. We need a network where we can all be there for each other and share both the challenges and solutions. If you haven’t already done so, please join our Patient Safety Leadership Association.”
“Today’s presentations at the World Patient Safety, Science & Technology Summit showed that there is a real need for patients and their families to work together with doctors, nurses, pharmacists, and therapists to challenge the current model and demand change so that health systems consistently deliver open and transparent access to the level of avoidable harm,” stated Dr. Mike Durkin, Chair of the PSMF Board of Directors and the former National Director of Patient Safety for the UK’s National Health Service. “They should also go further to challenge their political representatives to deliver health systems to provide equitable and inclusive delivery to every member of their population.”
Dr. Sanaz Massoumi, PSMF’s Chief Operating Officer, spoke next on forging the future of patient safety, stating, “Fostering a culture of safety is a holistic approach that engages the entire system in prioritizing patient safety at the core of every decision-making process, proactively assessing and mitigating risks.”
In a video-taped message presented during the morning session, Dr. Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization, alerted attendees to the challenges to patient safety posed by attacks on healthcare workers in areas of conflict, numbering more than 7,000 attacks in 21 different countries and territories resulting in over 2,200 deaths since 2018. He urged, “Health workers and health facilities must never be attacked and must be actively protected even in the most arduous conditions. We must take a united stand for the protection and safety of patients, health workers, and health facilities.”
The Rt Hon Jeremy Hunt MP, in another recorded message, told attendees how he got involved with Joe Kiani and the Patient Safety Movement Foundation and their efforts to persuade the World Health Organization to set up a World Patient Safety Day (which takes place on September 17). He remarked, “I was taken on this journey actually not by medical experts but by ordinary members of the public who’d lost loved ones in the most tragic of circumstances. That told me something needed to change.”
In the day’s first keynote, Dr. John Wyte, Chief Medical Officer at WebMD, discussed the impact of misinformation on patient safety at a time when more and more people are relying on internet searches for health-related information (one billion queries a day!), mobile apps, wearable devices, and other emergent technologies.
Representing the host venue for this year’s Summit, Dr. Michael Stamos, who serves as Dean of the UC Irvine School of Medicine, described how the UCI School of Medicine and the health center’s leadership are structured to optimally support an improved safety culture among physicians and staff and to promote better patient outcomes.
Updating attendees on the US Department of Health and Human Services’ efforts to improve patient safety, Amy Ashcraft, Deputy Regional Inspector General from the Office of Inspector General, emphasized the importance of tracking and reporting all harm incidents and data transparency. She also outlined HHS’s initiatives to protect patients through the Agency for Healthcare Research and Quality (AHRQ) and Center for Medicare and Medicaid Services (CMS).
Dr. Daniel Cole, the Executive Director for Professional Affairs at the American Board of Anesthesiology, explored the transformative impacts of emerging technologies, including remote monitoring devices, medical imaging, and healthcare data analytics, on perioperative care.
Using advanced technologies, including AI, to help protect patients and improve their care was an important theme throughout this year’s Summit. Dr. Michael Ramsay, PSMF’s Chief Executive Officer, observed, “We are at an important crossroads in the evolution of patient safety. New technologies enable us to monitor patient vitals remotely, AI can be used as a check against misdiagnosis and to predict harm events, and telehealth expands healthcare access and equity. Through our ongoing collaborative efforts and sharing data, healthcare providers in partnership with Med-Tech, government agencies, patients, and other stakeholders can protect patients in ways that were unimaginable a decade ago.”
Like the keynote presentations, panels during the Summit’s second day continued to build on the previous day’s insights and momentum. In one panel, leading patient advocates addressed the important issue of engaging patients and their family members, and Dr. Mike Durkin led another panel to discuss the state of affairs in patient safety around the world.
PATIENT SAFETY MOVEMENT FOUNDATION
In 2012, Joe Kiani founded the non-profit Patient Safety Movement Foundation to eliminate preventable medical errors in hospitals. His team worked with patient safety experts from around the world to create Actionable Evidence-Based Practices that address top challenges. Hospitals can make a formal commitment to ZERO preventable deaths, and healthcare technology companies are asked to sign the Open Data Pledge to share their data so that predictive algorithms can be developed to identify errors before they become fatal. The PSMF was established through the support of the Masimo Foundation for Ethics, Innovation, and Competition in Healthcare.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240907191633/en/
Contacts
Patient Safety Movement Foundation
Irene Mulonni, irene@mulonni.com | (858) 859-7001
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
30 Peer-Reviewed Studies Highlight Statistically Significant Health Benefits of Almased16.7.2025 10:15:00 EEST | Press release
Two recent, peer-reviewed clinical studies have found that Almased, a high-protein, low-glycemic meal replacement, delivers significant health benefits ranging from weight loss and improved metabolic health to anti-aging effects and enhanced quality of life. Both reviews synthesize 30 peer-reviewed clinical studies across three decades of scientific research, confirming that Almased is effective and safe for weight reduction, preservation of lean muscle mass, and cardiovascular health. The 2025 review in the American Journal of Biomedical Science & Research highlighted Almased’s efficacy and safety for wide groups of people including individuals seeking weight loss, those with metabolic syndrome or fatty liver, older adults needing to preserve muscle mass, and athletes or healthy-weight individuals who require additional high-quality protein. This review also discusses how Almased’s patented fermentation process produces over 80 bioactive peptides, including 2 times the average daily i
Skechers AERO Series Opens New Chapter of Technical Running Innovation16.7.2025 10:00:00 EEST | Press release
Skechers Performance opens a new chapter of running innovation with the arrival of the Skechers AERO series. Named for the aerodynamic feel of the design, Skechers AERO represents the latest evolution of technical running shoes from the brand. The collection is engineered to deliver an exhilarating blend of speed, style and comfort to help runners cut through the wind and push beyond their personal bests while logging miles. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250716754749/en/ Introducing the Skechers AERO Series of technical running shoes: Skechers AERO Burst, Skechers AERO Spark, and Skechers AERO Tempo (L-R). “Recently launched in North America and Asia, the AERO Series leverages innovative technologies to elevate our signature comfort that’s now available to runners in Europe,” said Ben Stewart, Vice President, Skechers Technical Performance Division. “An evolution of our legacy in running, Skechers AERO was d
The Future of Connectivity Starts Here: Network X Returns to Paris October 14 - 1616.7.2025 10:00:00 EEST | Press release
Network X 2025 - the only event that brings the fixed and mobile markets together - returns to Paris Expo Porte de Versailles October 14 - 16. Built for telecom's top players, this annual show drives business model innovation and monetisation of next-generation fixed, mobile, satellite and transport networks through AI and cloud. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250716595903/en/ Speaker on Headliners Stage at Network X 2024 New to Network X in 2025 are specialty events designed to deliver expert insights on trending topics including Data Center World and two Expo Stages for Fixed-Line and Mobile. More than 5,500 telco network infrastructure professionals will gather alongside 1,500 telcos to learn from six program tracks highlighting the latest advancements in Fibre, Wi-Fi Networks and Services, IP and Optical Transport, Mobile Networks, Mobile Services, and Data Centres. “Network X is more than a conference—it
4Moving Biotech Enrolls First Patient in Phase 2a Trial of 4P004, a Potential First-in-Class GLP-1 Therapy for Knee Osteoarthritis16.7.2025 08:00:00 EEST | Press release
4Moving Biotech (4MB), a spin-off of 4P-Pharma dedicated to developing first-in-class treatments that modify the natural course of knee osteoarthritis (OA), today announced that the first patient has been enrolled in Phase 2a clinical trial, INFLAM MOTION. The study will evaluate 4P004, an intra-articular GLP-1 analog, as a potential first-in-class therapeutic candidate for knee osteoarthritis. INFLAM MOTION is a multicenter, randomized, double-blind, placebo-controlled Phase 2a trial planned to be conducted across Europe, the United States, and Canada. A total of 129 patients worldwide diagnosed with knee OA will be enrolled to evaluate, for the first time in humans, the efficacy of 4P004. “Enrolling our first patient is a pivotal step toward rewriting the treatment paradigm for knee osteoarthritis,” said Professor Francis Berenbaum, MD, PhD, Chief Medical Officer at 4Moving Biotech. “Almost 600 million people live with OA, yet no disease-modifying therapy has been done to patients. B
Belkin Achieves Qi2.2 Certification for Its Upcoming Products, Unlocking the Future of 25W Wireless Charging15.7.2025 20:06:00 EEST | Press release
Belkin, a leading consumer electronics brand for over 40 years, today announced it has received official Qi2.2 certification from the Wireless Power Consortium (WPC) for its upcoming products. As one of the first accessory brands to deliver Qi2.2-certified devices, Belkin is helping bring the next generation of wireless charging to market – enabling faster wireless charging speeds, broader compatibility, and improved performance for consumers. Belkin’s close partnership with the WPC since 2015 has been instrumental in bringing these advancements to consumers. As an early adopter and long-time contributor to WPC standards, Belkin was selected as one of a small group of trusted manufacturers to test and certify Qi2.2 products ahead of the broader industry rollout. All Belkin products undergo rigorous safety, quality, and performance testing. The company’s global headquarters includes WPC certified test equipment and state-of-the-art test labs dedicated to full product lifecycle validatio
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom